← Back to markets
Helus Pharma
HELP · Health Care · Pharmaceuticals
$11.60-0.09%
RS +95.8
Returns
| 7D | +48.5% |
| 1M | +75.1% |
| 3M | +117.4% |
| 6M | +98.1% |
| YTD | +41.9% |
| 1Y | +55.6% |
About Helus Pharma
Helus Pharma, also known formerly as Cybin IRL, is a Canadian pharmaceutical company that was led by CEO Doug Drysdale from 2020-2025, developing psychedelic drugs as medicines.